Stonerise team members across the Stonerise Network have been remarkably resilient, loving and dedicated during the pandemic’s toughest days and continue to do so today. Stonerise Achieves Healthy Patient Outcomes Across Service Lines.
By Dr. Anita Lorenzo, Director of Clinical Pharmacy Services
Bamlanivimab (BAM), a monoclonal antibody therapy, is a drug now used widely to help individuals overcome COVID-19 and has proven instrumental in putting many Stonerise patients on the path to recovery from the virus. However, without the efforts of members of our clinical leadership team, this treatment may have not been so quick to reach patients.
Stonerise Therapy delivered in 2020 resulted in better outcomes for our Stonerise Therapy patients than the national norms. Our patients scored higher on their outcome measures and did so in a shorter duration of time than their comparison group.